🔗 Share this article

Acclaimed R&B singer D’Angelo died on October 14 at age 51 after a personal fight with pancreatic malignancy.

“The shining star of our household has dimmed his light for us in this life,” his family confirmed. “After a lengthy and brave battle with cancer, we are heartbroken to declare that Michael D’Angelo Archer, recognized by his fans around the world as D’Angelo, has been called home.”

D’Angelo made a lasting impact on music with his pioneering neo-soul sound and collaborations with high-profile artists.

He released his first record, “Brown Sugar,” in 1995 to immediate acclaim. The record reached No. 4 on the R&B charts, went platinum soon after, and earned several award nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that boosted his music career into the stratosphere. The record debuted at No. 1 on both Billboard’s Top R&B Albums chart and the main album chart. He won two Grammy Awards: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a reluctant one, in the cultural zeitgeist. The personal depiction featured the artist, notably stripped down to his waist, performing directly into the camera.

D’Angelo stepped back from the public eye after releasing Voodoo and publicly struggled with drugs and alcohol. In 2005, he was involved in a serious car crash that put him in critical condition.

Over ten years later, his last record, “Black Messiah” (2014), confirmed his enduring appeal with a further No. 1 debut on the soul music rankings and a Grammy for Top R&B Record.

Once more, in his own enigmatic way, D’Angelo made only a few public appearances in the subsequent period.

The musician was scheduled as a top act for the 2025 Roots Picnic festival, but his performance was called off, citing an “unexpected health issue.”

Even though information is limited about D’Angelo’s well-being in the weeks before his death, he had apparently been hospitalized for months and in palliative care for two weeks.

D’Angelo’s passing is a clear example of the devastating effects of pancreatic malignancy, one of the most deadly and least preventable types of the illness, on a gifted artist whose life was cut short.

“We are grieved that he can only provide cherished moments with his family, but we are eternally grateful for the heritage of deeply emotional music he leaves behind,” his kin expressed.

Pancreatic Malignancy: Deadly and Difficult to Avoid

Pancreatic malignancy affects the digestive organ, a tiny gland that generates the hormone insulin and is vital in breaking down food, among additional roles. The position and dimensions of the pancreas in the body make it more difficult to detect malignancy.

Even though pancreatic cancer makes up only about 3% of cancer diagnoses each year in the U.S., it is causes 7% of malignancy fatalities.

Almost 70,000 individuals will be found to have pancreatic cancer and about fifty-two thousand will succumb to the disease in the year 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have few and poor therapies, and a smaller window to make a significant difference on the well-being of patients,” said a medical oncologist.

Because this disease seldom produces initial signs, it’s frequently diagnosed only after the disease is advanced. Even when a patient has indicators they are usually vague and may be mistaken for a number of common illnesses.

“As of yet, there is no effective method to detect pancreatic cancer in the early stages, apart from listening to your body and consulting your physician if there are new or unusual symptoms,” said a health expert.

Frequent indicators of this disease include:

• discomfort in the stomach or back
• reduced body mass
• yellowing of skin and eyes
• reduced hunger
• brownish urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s demise is an exception, as this malignancy is most common in individuals in the sixty-five to seventy-five age bracket. However, numerous malignancies, such as this type, have become increasingly prevalent in younger people.

“This disease identified before the age of 50 is deemed rare, yet alarmingly, doctors are noticing a rising count of younger patients affected by this condition,” commented a expert.

Family History Impacts Disease Probability

Without effective detection methods for this malignancy, experts emphasized the significance of knowing your family’s health background. Certain contributing elements, such as smoking and obesity also play a role in the onset of pancreatic cancer.

African Americans have the highest incidence of pancreatic cancer in the United States and are more prone to be diagnosed with inoperable cancer.

“The first step toward reducing one’s risk of this condition is understanding personal risk factors. Individuals should examine their family history, hereditary factors, and health issues, such as blood sugar disease, chronic pancreatitis, or overweight that may increase their susceptibility,” advised a specialist.

Inherited genetic risk factors are linked to as much as 10% of all this malignancy cases. If someone in your family has had pancreatic cancer, you may want to think about DNA analysis.

“For people with a relative’s background of pancreatic cancer or those having high risk DNA changes, screening may involve advanced imaging such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to detect early changes in the organ,” he clarified.

For those looking to lower their chance, lifestyle changes may make a difference. The best action you can take to reduce your susceptibility of this disease is to stop tobacco use, and if you don’t smoke, avoid exposure altogether.

Excessive alcohol consumption is linked to pancreas inflammation, a risk factor for this malignancy, so limiting or avoiding drinks may help reduce your risk.

Managing your weight or shedding pounds may also aid decrease your susceptibility. People with obesity are 20% more likely to develop pancreatic cancer. This malignancy also is more frequent in those with blood sugar issues, and reducing weight can also lower the risk of type 2 diabetes.

Despite pancreatic cancer’s grim outlook, there is still hope.

“We are making progress with treatments and newer mixed drug treatments. There are developing targeted therapies that already are showing results,” said a expert.

For many people, however, education about this rare but {dev